Literature DB >> 699505

Analytical subcellular fractionation of jejunal biopsy specimens: enzyme activities, organelle pathology and response to corticosteroids in patients with non-responsive coeliac disease.

T J Peters, P E Jones, W J Jenkins, G Wells.   

Abstract

1. Jejunal biopsies from five patients with non-responsive coeliac disease have been subjected to analytical subcellular fractionation and enzymic microassay in order to compare the organelle pathology of this group with untreated but glutensensitive patients. 2. Compared with the gluten-sensitive group these non-responsive patients showed marked reduction of the endoplasmic reticulum enzymes, normal activities of lysosomal enzymes and slightly less severely reduced brush border activities. 3. It is suggested that the present biochemical studies in combination with previous clinical reports and measurements of DNA and protein synthesis by cultured mucosal biopsies delineate non-responsive coeliac disease as a distinct entity. 4. The patients were treated with oral prednisolone (20 mg daily) for between 5 and 9 weeks and the properties of the jejunal biopsies restudied. 5. Although morphologically there was only a partial restoration of the villus architecture the enzymic alterations and organelle abnormalities returned essentially to normal values.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699505     DOI: 10.1042/cs0550293

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  7 in total

1.  Coeliac disease: A review of the causative agents and their possible mechanisms of action.

Authors:  H J Cornell
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

2.  Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.

Authors:  S Somasundaram; S Rafi; J Hayllar; G Sigthorsson; M Jacob; A B Price; A Macpherson; T Mahmod; D Scott; J M Wrigglesworth; I Bjarnason
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

3.  Protein synthesis by cultured jejunal mucosa from control subjects and patients with coeliac disease.

Authors:  P E Jones; C L L'Hirondel; T J Peters
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

4.  Oral zinc supplements in non-responsive coeliac syndrome: effect on jejunal morphology, enterocyte production, and brush border disaccharidase activities.

Authors:  P E Jones; T J Peters
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

5.  Small bowel enema in non-responsive coeliac disease.

Authors:  N Mike; U Udeshi; P Asquith; J Ferrando
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

6.  Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations.

Authors:  C O'Morain; P Smethurst; A J Levi; T J Peters
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

7.  A pilot study of fluticasone propionate in untreated coeliac disease.

Authors:  H C Mitchison; H al Mardini; S Gillespie; M Laker; A Zaitoun; C O Record
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.